Vanguard Global Advisers’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Vanguard Global Advisers's WST Position: Q3 2026 in Review
Vanguard Global Advisers increased its West Pharmaceutical (WST) stake by 2.7% in Q3 2026, buying an estimated $1.44M and bringing the position to 156,210 shares worth $57.9M. The position accounts for 0.03% of the portfolio, ranked #382.
Vanguard Global Advisers first reported a position in WST in Q1 2026 and has held it in 3 quarters since. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Vanguard Global Advisers held 156,210 shares of West Pharmaceutical worth $57.9M as of Q3 2026.
- Vanguard Global Advisers bought 4,086 West Pharmaceutical shares in Q3 2026, an estimated $1.44M.
- West Pharmaceutical made up 0.03% of Vanguard Global Advisers's portfolio in Q3 2026, its #382 holding.
- Vanguard Global Advisers first reported a position in West Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
- 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.